U.S. FDA approves first mRNA flu shot from Moderna
The shot, mFlusiva, was given a traditional approval for adults aged 50 to 64, and an accelerated approval for those 65 years and older
We haven't written up this one. The Hindu Health has the full story — the link below goes straight to it.



